H2 Biopharma buyout by Aurora Cannabis finalized at USD 25 million
Date: 2017-11-24   Author: Dhananjay Punekar  Category: #news

H2 Biopharma buyout by Aurora Cannabis finalized at USD 25 million

Aurora Cannabis Incorporation, a Canada based medical marijuana producer, has reportedly declared that it is all set to acquire the reputed Quebec based late phase ACMPR applicant, H2 Biopharma Incorporation, through a binding stock buyout transaction. According to the reliable sources, the former is expected to make a total payment of nearly USD 25 million for the proposed acquisition, including the closing as well as milestone payments. The buyout apparently, is expected to mark Aurora’s fourth production facility in Canada and the second facility in Quebec along with its 40,000 sq. feet production facility – called the “Aurora Vie” on Montreal island. It has also been stated that this acquisition deal is subject to the regulatory approval by the Toronto Stock Exchange.

If reports are to be believed, H2 Biopharma Incorporation is on the verge of completing its purpose-built cannabis production facility spread over 48000 sq. feet, which is located in the vicinity of Montreal and the Pierre-Elliott Trudeau International Airport. This Lachute facility, which is anticipated to produce nearly 4,500 kg of high quality marijuana each year, reportedly has the access to water and inexpensive power supply supported by better infrastructure. H2’s acquisition, thus, will help Aurora to further expand the capacity of this production facility and improve its overall marijuana output, cite renowned industry analysts.

Apparently, it has been observed that there is an excessive demand for legalized & regulated cannabis items across the domestic as well as globally evolving markets. By means of leveraging its current financial position, outstanding liquidity record, in conjunction with its long years of experience to create technologically modernized cannabis units, Aurora, say experts, is anticipated to achieve top-notch output and asset distribution at an attractive price-value. Furthermore, this deal has also been declared to fulfill the regional as well as global demand for cannabis products, cite reports.  



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

Gojek and TTD announce a new partnership for O2O measurement solution
Author: Pankaj Singh

Gojek, a renowned Indonesian technology company, and The Trade Desk (TTD), a US-based software technology company, together announced an exclusive collaboration to offer unprecedented insight to advertisers in the impa...


Medical imaging firm Nanox raises $26M in a round led by Foxconn
Author: Saipriya Iyer

Nanox Imaging, an Israeli medical imaging startup, reportedly announced that it raised $26 million in an investment round, which was led by its strategic investor Foxconn. The total valuation of the company has reached...


Fitbit adds blood oxygen level monitoring feature in some devices
Author: Saipriya Iyer

Fitbit- a California based fitness wearables company has reportedly rolled out SpO2 sensors in its devices, enabling users to track their blood oxygen levels. In terms of percentage, between 95% to 100% of blood oxygen...